Fundraising Fox

Inflammatix

2 known investors

inflammatix.com ↗

Inflammatix develops host-response-based molecular diagnostics tests to identify acute infections and sepsis in emergency and critical care settings. The company's diagnostic platform serves healthcare providers treating acutely ill patients, with applications extending to emerging infectious diseases, autoimmune conditions, and transplant rejection.

AI & Machine LearningBiotechHealthtechMedical Devicesin /inflammatix@inflammatix_inc

Founders & leadership

TS
Tim SweeneyCo-Founder and CEO
PK
Purvesh KhatriCo-Founder and Chief Scientist

Investors · 2

Khosla Ventures✓ verifiedMenlo Park
Northpond Ventures✓ verifiedBethesda

In the news